Rotenberg Nir Shlomo - 18 Mar 2026 Form 3 Insider Report for SHL TELEMEDICINE LTD (SHMLF)

Reporting relationship: Director
Issuer ticker: SHMLF
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 25 Mar 2026, 09:18:18 UTC
Source filing: View source filing
Reporting owner signature: /s/ Rotenberg Nir Shlomo

Key filing fact

Rotenberg Nir Shlomo filed Form 3 for SHL TELEMEDICINE LTD (SHMLF) on 25 Mar 2026.

Key facts

This page summarizes Rotenberg Nir Shlomo's Form 3 filing for SHL TELEMEDICINE LTD (SHMLF).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 25 Mar 2026, 09:18.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002117820 Primary reporting owner

Rotenberg Nir Shlomo

Relationship: Director
Address: C/O SHL TELEMEDICINE LTD., 90 YIGAL ALON STREET, TEL AVIV, ISRAEL
Signature: /s/ Rotenberg Nir Shlomo
Signature date: 17 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SHMLF holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 175,562
Date: 18 Mar 2026
Ownership: Direct

SHMLF holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,165,620
Date: 18 Mar 2026
Ownership: See Footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents ordinary shares beneficially owned by Danbar Finance Ltd., a private investment group located in Israel ("Danbar"), of which Mr. Rotenberg is the Chairman of the Board and has served there as a director and partner since 2000. Mr. Rotenberg disclaims beneficial ownership of the securities beneficially owned by Danbar except to the extent of his pecuniary interest therein.

SEC remarks

This Form 3 is filed pursuant to the Holding Foreign Insiders Accountable Act (HFIAA), which extends Section 16(a) reporting obligations to directors and officers of Foreign Private Issuers effective March 18, 2026.